IPP Bureau
Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
By IPP Bureau - June 26, 2026
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer
By IPP Bureau - June 26, 2026
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Reliance-backed Karkinos Healthcare crosses 1 lakh cervical cancer screening in India
By IPP Bureau - June 26, 2026
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Eli Lilly seals Centessa acquisition as it bets big on next-gen sleep disorder drugs
By IPP Bureau - June 26, 2026
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
BOTOX Cosmetic selects 2026 women entrepreneurs for Confidence Collective Program
By IPP Bureau - June 26, 2026
BOTOX Cosmetic is providing participants with training resources, mentorship, and— for 20 selected founders— access to business-boosting capital
Prince Chaudhary joins Medicamen Biotech as Deputy General Manager
By IPP Bureau - June 26, 2026
Over the course of his career, he has also held leadership roles at Pfizer, Alembic Pharmaceuticals, and Cipla
Govt includes vaccines, antimicrobials, NDPS and anti-cancer drugs under QR code authentication
By IPP Bureau - June 26, 2026
Health ministry notifies amendments to the Drugs Rules, 1945 to expand the ambit of Schedule H2 and bring additional categories of drugs under the QR Code-based track and trace framework
Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal
By IPP Bureau - June 25, 2026
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
Experts call for uniform quality standards for blood and blood components
By IPP Bureau - June 25, 2026
National conference brings together 160+ experts from six states to advance blood quality and safety standards
Mardamed unveils 15,000 sq. ft. HeX Centre integrating healthcare with everyday retail
By IPP Bureau - June 25, 2026
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
By IPP Bureau - June 25, 2026
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore
By IPP Bureau - June 25, 2026
The resolution significantly reduces a long-standing contingent liability from the company's books
Mankind Pharma launches nationwide preventive oncology initiative to reach one million women
By IPP Bureau - June 25, 2026
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
Eli Lilly India launches Tanstrive for RET-altered cancers
By IPP Bureau - June 25, 2026
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform
By IPP Bureau - June 25, 2026
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
